[HTML][HTML] Therapeutic potential of exosome‐based personalized delivery platform in chronic inflammatory diseases
C Wang, M Xu, Q Fan, C Li, X Zhou - Asian journal of pharmaceutical …, 2023 - Elsevier
In the inflammatory microenvironment, there are numerous exosomes secreted by immune
cells (Macrophages, neutrophils, dendritic cells), mesenchymal stem cells (MSCs) and …
cells (Macrophages, neutrophils, dendritic cells), mesenchymal stem cells (MSCs) and …
Engineering and loading therapeutic extracellular vesicles for clinical translation: A data reporting frame for comparability
Extracellular vesicles (EVs) have emerged as new drug delivery systems as well as a
regenerative cell-free effectors going beyond academic research to reach industrial …
regenerative cell-free effectors going beyond academic research to reach industrial …
Neutrophil membrane-derived nanovesicles alleviate inflammation to protect mouse brain injury from ischemic stroke
Ischemic stroke is an acute and severe neurological disease, resulting in disability and
death. Reperfusion to an ischemic brain is a means to reverse brain damage after stroke; …
death. Reperfusion to an ischemic brain is a means to reverse brain damage after stroke; …
The functional heterogeneity of neutrophil-derived extracellular vesicles reflects the status of the parent cell
Similar to other cell types, neutrophilic granulocytes also release extracellular vesicles
(EVs), mainly medium-sized microvesicles/microparticles. According to published data …
(EVs), mainly medium-sized microvesicles/microparticles. According to published data …
Drug delivery to the inflamed intestinal mucosa–targeting technologies and human cell culture models for better therapies of IBD
O Hartwig, MAS Boushehri, KS Shalaby… - Advanced Drug Delivery …, 2021 - Elsevier
Current treatment strategies for inflammatory bowel disease (IBD) seek to alleviate the
undesirable symptoms of the disorder. Despite the higher specificity of newer generation …
undesirable symptoms of the disorder. Despite the higher specificity of newer generation …
COVID-19 inflammation and implications in drug delivery
Growing evidence indicates that hyperinflammatory syndrome and cytokine storm observed
in COVID-19 severe cases are narrowly associated with the disease's poor prognosis …
in COVID-19 severe cases are narrowly associated with the disease's poor prognosis …
Engineering bacterial membrane nanovesicles for improved therapies in infectious diseases and cancer
Research on bacterial membrane vesicles (BMVs) is an emerging topic, and the goal is to
address whether BMVs can bring translational tools to improve current therapies. In this …
address whether BMVs can bring translational tools to improve current therapies. In this …
Human neutrophil membrane-derived nanovesicles as a drug delivery platform for improved therapy of infectious diseases
Resolvins are a group of specialized proresolving lipid mediators (SPMs) enzymatically
produced from omega-3 fatty acids during acute inflammation response to infections or …
produced from omega-3 fatty acids during acute inflammation response to infections or …
Generation, purification and engineering of extracellular vesicles and their biomedical applications
Extracellular vesicles (EVs), derived from cell membranes, demonstrate the potential to be
excellent therapeutics and drug carriers. Although EVs are promising, the process to …
excellent therapeutics and drug carriers. Although EVs are promising, the process to …
[HTML][HTML] RGD-expressed bacterial membrane-derived nanovesicles enhance cancer therapy via multiple tumorous targeting
Background: A tumor microenvironment is a complicated multicellular system comprised of
tumor cells, immune cells and blood vessels. Blood vessels are the barriers for drug tissue …
tumor cells, immune cells and blood vessels. Blood vessels are the barriers for drug tissue …